NYSEARCA:TMBR - NYSE Arca - US8870802084 - Common Stock - Currency: USD
Timber Pharmaceuticals (TMBR) announces immediate suspension of common stock trading on NYSE America, expected to continue trading on OTC Market as TMBRQ.
WARREN, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. (
WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical...
Timber Pharmaceuticals (TMBR) reportedly filed for Chapter 11 bankruptcy protection Friday afternoon after shareholders again refused to approve a planned merge
Timber Pharmaceuticals, Inc. (NYSE: TMBR) has
Timber Pharmaceuticals (TMBR) shares fall ahead of a crucial shareholder meeting on Friday regarding its proposed merger with LEO Pharma. Read more here.
WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (
Timber Pharmaceuticals (TMBR) shares soared 100% Monday after the biotech company said it had agreed to be taken private by Danish dermatology company LEO Pharma. Read more here.
Biopharmaceutical company Timber Pharmaceuticals (TMBR) Monday entered into a definitive agreement to be acquired by Danish pharmaceutical company LEO Pharma.The transaction was valued...
Skillz (SKLZ) stock is taking off on Monday after the mobile gaming company announced plans for a share repurchase program.
Timber Pharmaceuticals (TMBR) stock is undergoing a rally on Monday after announcing that Leo US is acquiring it in a $36 million deal.
Transaction Provides Timber Stockholders with Upfront Cash Consideration and Downstream Value through Contingent Value RightsTotal Transaction Value of up...
Biopharmaceutical company Timber Pharmaceuticals (TMBR) said on Monday that it had received NYSE American notice on non-compliance with the stock exchange's rules related to...
WARREN, NJ, July 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a...
Shares of micro-cap Timber Pharmaceuticals (TMBR) soared as much as 83% on Monday after the company was granted a FDA waiver to forgo a rodent study for TMB-001.
During Monday's intraday session, major market indexes traded mixed as investors tried to assess the likelihood of the Fed hiking interest rates again next week.Looking at the...
During Monday's intraday session, major market indexes traded mixed as investors tried to assess the likelihood of the Fed hiking interest rates again next week.Looking at the...